The antidepressant effect of sertraline is not enhanced by dose titration: Results from an outpatient clinical trial

International Clinical Psychopharmacology

Volumn 16, Issue 3, 2001, Pages 137-143

  Schweizer, E ^a   Rynn, M ^a   Mandos, L A ^a,c   DeMartinis, N ^b   Garcia Espana F ^a   Rickels, K ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

Antidepressant drugs; Depression; Dose escalation; Dose response; Double blind study; Sertraline

Indexed keywords

SERTRALINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DOSE CALCULATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTPATIENT CARE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REMISSION; SEXUAL DYSFUNCTION; TITRIMETRY; TREATMENT FAILURE; TREATMENT OUTCOME; XEROSTOMIA;

EID: 0035030253     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200105000-00002     Document Type: Article

References (18)

1. Dose escalation versus continued doses of paroxetine and maprotiline: A prospective study in depressed out-patients with inadequate treatment response
2. Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials
3. Sertraline safety and efficacy in major depression: A double-blind fixed-dose comparison with placebo
4. SSRIs versus other antidepressants for depressive disorder
5. A rating scale for depression
6. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders
7. Treatment received by depressed patients
8. The Hopkins Symptom Checklist (HSCL) - Factors derived from the HSCL-90
9. Early nonresponse to fluoxetine as a predictor of poor 8-week outcome
10. Sertraline 50 mg daily: The optimal dose in the treatment of depression
11. Duration of antidepressant drug treatment. What is an adequate trial?
12. Strategies and tactics in the treatment of depression
13. What constitutes an adequate antidepressant trial for fluoxetine?
14. The efficacy of sertraline in panic disorder: Combined results from 2 fixed-dose studies
15. Pharmacological choices after one antidepressant fails: A survey of UK psychiatrists
16. When at first you don't succeed ... sequential strategies for antidepressant nonresponders